FDA Approved a Total of 39 New Drugs in 2012 — Fifteen Year High

Research Driven Investing Provides Stocks Research on Idenix and Orexigen

Continue Reading

Number of FDA Drug Approvals Reach a 15-Year High in 2012

Research Driven Investing Provides Stocks Research on Cleveland BioLabs and Hyperion Therapeutics

Continue Reading

Interest in Gold as a Safe Haven Increases as GDP Contracts for the First Time in 3.5 Years

Five Star Equities Provides Stock Research on IAMGOLD and New Gold

Continue Reading

S&P 500 Companies Projected to Report a 3.8% Growth in Earnings — S&P 500 Index Hits 5-Year High

Research Driven Investing Provides Stocks Research on The Clorox Company and Leggett & Platt

Continue Reading

Gold Posts Largest Gain in Over Three Week as the Nation-s GDP Drops Unexpectedly in the Fourth Quarter

Five Star Equities Provides Stock Research on Golden Star Resources and Harmony Gold Mining

Continue Reading

BioFuel Industry Look to Benefit From Potential Increase of the Renewable Fuels Mandate by the FDA

Five Star Equities Provides Stock Research on Renewable Energy Group and Solazyme

Continue Reading

Strong Performance From Downstream Operations Help Drive Earnings for Chevron and Exxon Mobil

Research Driven Investing Provides Stocks Research on Chevron and Exxon Mobil Corporation

Continue Reading

Investment Case for Gold Robust Heading Into 2013 — GDP Unexpectedly Shrinks in the Fourth Quarter

Five Star Equities Provides Stock Research on AuRico Gold and Yamana Gold

Continue Reading

Environmental Protection Agency Proposes to Increase Renewable Fuels Mandate by 8.9%

Five Star Equities Provides Stock Research on Archer Daniels Midland and Green Plains

Continue Reading

JDS Uniphase and Pitney Bowes Rise on Fourth Quarter Earnings — S&P 500 Index Hovers Near 5-Year Highs

Research Driven Investing Provides Stocks Research on JDS Uniphase and Pitney Bowes

Continue Reading